Characteristics of Facilities with Early and Rapid Ustekinumab Adoption for Patients with Inflammatory Bowel Disease.
Shirley Cohen-MekelburgTony VanJeffrey A BerinsteinXianshi YuDeena Kelly CostaBeth I WallaceSameer SainiAndrew J AdmonPeter D R HigginsJi ZhuAkbar K WaljeePublished in: The American journal of gastroenterology (2023)
Facility variation in medication adoption provides an opportunity for improving IBD care through targeted dissemination strategies to improve medication uptake.